慢性乙型肝炎患者肝组织病理学分析

Abstract

Abstract: Objective To investigate the relationship among serum HBV DNA,ALT,ALB,PT levels and liver tissue injuries in patients with chronic hepatitis B. Methods Routine biochemical liver function tests and serum HBV DNA levels were assayed in 252 patients with chronic hepatitis B,and the liver biopsies were performed and the grading and staging of the liver were routinely obtained. Results There was not obvious correlation between the inflammatory grading and fibrotic staging;Serum ALT and PT in patients with G4 were significantly higher than in with G1;Serum HBV DNA levels was not correlated with histological activity index or firbosis. Conclusion Liver biopsy still plays an unique role in judging the pathogenetic condition of liver in patients with chronic hepatitis B.

Key words: Hepatitis B, HBV DNA, Liver tissue, Pathology

NIU Zhiling, GAO Shengli, YU Jing, et al.. Pathological and clinical analysis of liver biopsies in patients with chronic hepatitis B[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2010, 13(1): 26-27.

References

[1] KEEFFE EB,DIETERICH DT,HAN SH,et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States：2008 update[J]. Clin Gastroenterol Hepatol,2008,6（12）：1315-1341.
[2] LOK AS,MCMAHON BJ. Chronic hepatitis B：update 2009[J]. Hepatology,2009,50（3）：661-662.
[3] FOUCHER J,CASTERA L,BERNARD PH,et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations[J]. J Gastroenterol Hepatol,2006,18（4）：411-412.
[4] WAI CT,CHENG CL,WEE A,et al. Non-invasive models for predicting histology in patients with chronic hepatitis B[J]. Liver Int,2006,26（6）：666-672.
[5] LEBENSZTEJN DM,SKIBA E,SOBANIEC-LOTOWSKA M,et al. A simple noninvasive index （APRI） predicts advanced liver fibrosis in children with chronic hepatitis B[J]. Hepatology,2005,41（6）：1434-1435.
[6] 中华医学会传染病与寄生虫病学分会和肝病学分会. 病毒性肝炎防治方案[J]. 中华肝脏病杂志. 2000,8（6）：324-329.
[7] 赵登蕴,覃亚勤,刘贵章,等. 慢性HBV感染者临床与病理诊断的此较——附187例报告[J]. 实用肝脏病杂志,2007,10（5）：318-319.
[8] BATALLER R,NORTH KE,BRENNER DA. Genetic polymorphisms and the progression of liver fibrosis：a critical appraisal[J]. Hepatology,2003,37（3）：493-503.
[9] FALLETI E,FABRIS C,TONIUTTO P,et al. Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C[J]. Interferon Cytokine Res,2007,27（3）：239-246.
[10] PAPATHEODORIDIS GV,PARASKEVIS D. Role of genetic polymorphisms in the progression of liver fibrosis in chronic hepatitis C virus infection[J]. Liver Int,2008,28（6）：764-766.
[11] YIM HJ,LOK AS. Natural history of chronic hepatitis B virus infection：what we knew in 1981 and what we know in 2005[J]. Hepatology,2006,43（2 Suppl 1）：S173-S181.
[12] CHU CJ,HUSSAIN M,LOK AS. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection[J]. Hepatology,2002,36（6）：1408-1415.
[13] LAI M,HYATT BJ,NASSER I,et al. The clinical significance of persistently normal ALT in chronic hepatitis B infection[J]. Hepatology,2007,47（6）：760-767.
[14] 龙辉,罗红涛,赖春颜,等. 丙氨酸氨基转移酶低水平慢性乙型肝炎患者的肝脏病理分析[J]. 广东医学,2008,22（10）：1672-1674.
[15] 张玉果,南月敏. 慢性乙型肝炎临床与病理的对比分析[J]. 国际消化病杂志,2007,15（6）：468-469.

Pathological and clinical analysis of liver biopsies in patients with chronic hepatitis B

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[2]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[3]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[4]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[5]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[6]	Ma Liying, Shen Lijuan.. Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads [J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
[7]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[8]	Du Keye, Yang Dongliang, Liu Jia. Regulatory T cells in hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 613-616.
[9]	Liao Guichan, Peng Jie, Zhang Xiaoyong. Roles of hepatocytes in intrinsic innate immunity in control of hepatits B virus infection [J]. Journal of Practical Hepatology, 2019, 22(5): 617-619.
[10]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[11]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[12]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[13]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[14]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[15]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.